Mimicking nature's nanocarrier

Synthetic low-density lipoprotein-like nanoparticles for cancer-drug delivery

Ian R. Corbin, Gang Zheng

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Low-density lipoproteins have long been recognized as a viable nanocarrier for targeted delivery of drug and imaging agents. Many groups have published promising initial findings; however, progress in this field has been impeded by the need to isolate low-density lipoproteins from fresh donor plasma. In a recent paper by Nikanjam and colleagues, synthetic low-density lipoprotein-like nanoparticles were prepared from commercial lipids and a bifunctional synthetic peptide containing the low-density lipoprotein receptor-binding domain and the lipid-binding motif. These particles were shown to behave similarly to native low-density lipoproteins and also to bind to the low-density lipoprotein receptor on cancer cells. Herein, we evaluate the utility of this novel delivery vehicle and discuss what role this technology may have in nanomedicine.

Original languageEnglish (US)
Pages (from-to)375-380
Number of pages6
JournalNanomedicine
Volume2
Issue number3
DOIs
StatePublished - Jun 2007

Fingerprint

Lipoproteins
Drug delivery
LDL Lipoproteins
Nanoparticles
cancer
drug
LDL Receptors
Pharmaceutical Preparations
Neoplasms
Group
Nanomedicine
Medical nanotechnology
Lipids
lipid
Cells
Technology
Plasmas
Imaging techniques
peptide
Peptides

Keywords

  • Apoprotein B-100
  • Cancer
  • Low-density lipoprotein
  • Low-density lipoprotein receptor
  • Nanocarrier
  • Peptide

ASJC Scopus subject areas

  • Materials Science(all)
  • Bioengineering
  • Biomedical Engineering
  • Medicine (miscellaneous)
  • Development

Cite this

Mimicking nature's nanocarrier : Synthetic low-density lipoprotein-like nanoparticles for cancer-drug delivery. / Corbin, Ian R.; Zheng, Gang.

In: Nanomedicine, Vol. 2, No. 3, 06.2007, p. 375-380.

Research output: Contribution to journalArticle

@article{f368565b73c94a4ebcf5019923b42976,
title = "Mimicking nature's nanocarrier: Synthetic low-density lipoprotein-like nanoparticles for cancer-drug delivery",
abstract = "Low-density lipoproteins have long been recognized as a viable nanocarrier for targeted delivery of drug and imaging agents. Many groups have published promising initial findings; however, progress in this field has been impeded by the need to isolate low-density lipoproteins from fresh donor plasma. In a recent paper by Nikanjam and colleagues, synthetic low-density lipoprotein-like nanoparticles were prepared from commercial lipids and a bifunctional synthetic peptide containing the low-density lipoprotein receptor-binding domain and the lipid-binding motif. These particles were shown to behave similarly to native low-density lipoproteins and also to bind to the low-density lipoprotein receptor on cancer cells. Herein, we evaluate the utility of this novel delivery vehicle and discuss what role this technology may have in nanomedicine.",
keywords = "Apoprotein B-100, Cancer, Low-density lipoprotein, Low-density lipoprotein receptor, Nanocarrier, Peptide",
author = "Corbin, {Ian R.} and Gang Zheng",
year = "2007",
month = "6",
doi = "10.2217/17435889.2.3.375",
language = "English (US)",
volume = "2",
pages = "375--380",
journal = "Nanomedicine",
issn = "1743-5889",
publisher = "Future Medicine Ltd.",
number = "3",

}

TY - JOUR

T1 - Mimicking nature's nanocarrier

T2 - Synthetic low-density lipoprotein-like nanoparticles for cancer-drug delivery

AU - Corbin, Ian R.

AU - Zheng, Gang

PY - 2007/6

Y1 - 2007/6

N2 - Low-density lipoproteins have long been recognized as a viable nanocarrier for targeted delivery of drug and imaging agents. Many groups have published promising initial findings; however, progress in this field has been impeded by the need to isolate low-density lipoproteins from fresh donor plasma. In a recent paper by Nikanjam and colleagues, synthetic low-density lipoprotein-like nanoparticles were prepared from commercial lipids and a bifunctional synthetic peptide containing the low-density lipoprotein receptor-binding domain and the lipid-binding motif. These particles were shown to behave similarly to native low-density lipoproteins and also to bind to the low-density lipoprotein receptor on cancer cells. Herein, we evaluate the utility of this novel delivery vehicle and discuss what role this technology may have in nanomedicine.

AB - Low-density lipoproteins have long been recognized as a viable nanocarrier for targeted delivery of drug and imaging agents. Many groups have published promising initial findings; however, progress in this field has been impeded by the need to isolate low-density lipoproteins from fresh donor plasma. In a recent paper by Nikanjam and colleagues, synthetic low-density lipoprotein-like nanoparticles were prepared from commercial lipids and a bifunctional synthetic peptide containing the low-density lipoprotein receptor-binding domain and the lipid-binding motif. These particles were shown to behave similarly to native low-density lipoproteins and also to bind to the low-density lipoprotein receptor on cancer cells. Herein, we evaluate the utility of this novel delivery vehicle and discuss what role this technology may have in nanomedicine.

KW - Apoprotein B-100

KW - Cancer

KW - Low-density lipoprotein

KW - Low-density lipoprotein receptor

KW - Nanocarrier

KW - Peptide

UR - http://www.scopus.com/inward/record.url?scp=34250320123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250320123&partnerID=8YFLogxK

U2 - 10.2217/17435889.2.3.375

DO - 10.2217/17435889.2.3.375

M3 - Article

VL - 2

SP - 375

EP - 380

JO - Nanomedicine

JF - Nanomedicine

SN - 1743-5889

IS - 3

ER -